Background-Inflammatory bowel diseases are accompanied by alterations in the contractile function of colonic muscle. Whether these changes are also accompanied by the production ofinterleukin-l (IL-l,l) mRNA remains unknown. Aims-To investigate the profile of IL-1, mRNA in the colonic muscle of rats with acetic acid induced colitis. Methods-Colitis was induced by intrarectal administration of 1 ml of 40/0 acetic acid 8 cm from anal margin. Myeloperoxidase activity was used as a marker of inflammation in the colon. RNA was extracted from colonic muscle and was used to amplify the level of IL-1" mRNA with a reverse transcription coupled polymerase chain reaction (RT-PCR) method developed in this study. Results-Colonic muscle exhibited constitutive expression of IL-1" mRNA. The level was enhanced significantly, one, two, and five days after acetic acid administration. On day 7 after treatment, the level of IL-1" mRNA had returned baseline values. This profile of IL-1(S mRNA was consistent with myeloperoxidase activity.
The damage in inflammatory bowel diseases is primarily focused on the mucosa and submucosa, but the functions of muscle layers are also affected. Although the aetiology of these diseases remains unknown, they are regarded as inflammatory responses to a wide variety of unidentified antigens. 1 The diseases are characterised by changes in muscle function,2 alterations in the release of neurotransmitters, 3 and increases in cytokine concentration. 4 The molecular basis of the physiological changes and their mediators remains unknown.
Interleukin-1 ,B (IL-1 ,) is a pleiotropic molecule5 which regulates many events that occur in inflammation. For example, it has been implicated as a mediator of inflammation induced changes in nerve cell function6 and in vitro induction of proliferation of human muscle cells. 7 In vascular muscle it causes rapid relaxation. 8 Although mucosal expression of IL-13 has been shown in many studies during colitis, it is not known whether colonic muscle also elaborates the expression of IL-13P. Because muscle contractility is decreased during colitis,9 we hypothesised that expression of IL-1 B is increased in colonic muscle during colitis.
To identify the presence of IL-1P in colonic muscle, the IL-1,B mRNA during colitis induced in rats by acetic acid was measured as an index of gene activity. This and human IL-6 (normal font). Similarly the downstream primer PR2 (5'-GAGGTGCTG ATGTACCAGTTGCAGGCTGGACTGC AGGAAC-3') was made up of downstream primers of IL-,13 (in bold) and human IL-6 (normal font). Using PR1 and PR2 primers, a 391 base pair fragment (designated as ICOM-1) was amplified from human total RNA by RT-PCR, which was purified from gel'3 and quantitated spectrophotometrically (DU-70, Beckman). Thus the primers PR1 and PR2
were used only to create the sites of IL-113 primers PR3 (5'-ACAAAATACCTGTGG-CCTTGG-3') and PR4 (5'-GAGGTGCTG-ATGTACCAGTTG -3') in the human IL-6 fragment. The purified ICOM-1 competitive control was used to spike the RNA samples to quantify the level of IL-13 mRNA using PR3 and PR4 primers. Although the primers PR3 and PR4 were designed using mouse and human cDNA sequences,'7 18 they also amplified IL-1lB mRNA from rat samples. These primers were obtained from Genosys, UK.
ANALYSIS OF DATA
Ratios IL-1,:ICOM-1 and IL-13:13-subunit isoform were calculated from the areas of the bands scanned on a densitometer (Pharmacia, LKB) from the negatives. The changes in the level of IL-1,3 were calculated with respect to the control ratio taken as 100. A value of p<0 05 was considered to be significant.
Results

ESTIMATION OF MYELOPEROXIDASE ACTIVITY
Acetic acid causes epithelial erosion, loss of crypts, infiltration of inflammatory cells, bleeding, and diarrhoea, which were apparent one, two, and five days after treatment. The gut looked red and inflamed after one and two days of acetic acid but apparently normal after seven days (data not shown). Colitis was assessed by measuring the myeloperoxidase level in a segment of whole colon taken from the site of inflammation. The mean (SD) level of myeloperoxidase activity (units/min/g) (1-4 (0-9)) in the control rats was increased significantly after one (4 5 (1 1)), two (12 2 (2 5)), and five (29 (4)) days of acetic acid administration. However, after seven days myeloperoxidase activity (4 (0-9)) was not significantly different from the basal level. The level of myeloperoxidase activity after five days of acetic acid administration was not suppressed by indomethacin treatment (data not shown).
DEVELOPMENT OF THE RT-PCR METHOD
To estimate the level of IL-1 13 mRNA, we developed the present competitive RT-PCR method following the strategy outlined in Fig 1. A 391 bp DNA fragment was amplified from human total RNA using PR1 and PR2 primers (Fig 2, lane 2) . This fragment was designated as ICOM-1 and was used as a competitive control for the quantitation of IL-13 mRNA levels in the colonic RNA samples.
Although we used PR1 and PR2 to generate the sites of PR3 and PR4 primers in the IL-6 fragment for optimisation of the PCR conditions, in linear range amplification primers PR3 and PR4 were used. Serially diluted ICOM-1 samples (3-125, 6-25, 12-5, 25, 50, and 100 ng ICOM-1 respectively in lanes 6, 5, 4, 3, 2, and 1) amplified using PR3 and PR4 bp) in biological samples (Fig 4) . Figure 5 shows cycle dependent amplification of 25 ng of ICOM-1 and 250 ng total RNA, suggesting showed a concentration dependent that the method presented here is applicable zation of ICOM-1 (Fig 3) . These over a broad range of cycle settings and can be diluted samples were mixed with 500 further adapted for any application by adjustrse transcribed rat total RNA and were ing the amount of cDNA or cycle numbers. In -d using PR3 and PR4 primers (Fig 4) . order to obtain quantitative evaluation of these vel of ICOM-1 exhibited a concen-results, the areas of the bands from the negatives were obtained by scanning on a densitometer, Pharmacia, LKB (data not shown). Further, we evaluated the specificity of the primers PR3 and PR4 in different species including humans, mice, and rats. PR3 and PR4 primers amplified a 214 bp fragment from the total RNA obtained from humans ( Fig 6A,  lane 1 (Fig 6B, lane 2) , whereas the human IL-13 PCR fragment did not contain the BamHl site (Fig 6B, lane 1) . In rats ( Fig  6B, lane 3) , BamHl produced fragments of the size similar to the mouse, suggesting that the structure of IL-1 is similar in rats and mice.
PROFILE OF IL-il COLONIC MUSCLE
The level of IL-13 mRNA was estimated using the present PCR method in the RNA samples (Fig 7A) . There was constitutive expression of IL-13 mRNA in the colonic muscle of the untreated control rats (Fig 7B, lane 1) which increased significantly one (Fig 7B, lane 2) , two (Fig 7B, lane 3) and five days (Fig 7B, lane  4) was also amplified from each sample (Fig 7C) and the ratio IL-I13:13-subunit calculated. The data obtained with the present PCR method were compared with those obtained using the 1-subunit of sodium pump mRNA. As the In addition, IL-1 1 causes relaxation ofvascular muscle8 and is known to inhibit gastrointestinal motility in vitro.23 24 As the contractility of the muscle is also decreased during colitis,2 9 We also validated our findings with another internal control, the ,B-subunit of sodium pump which produced comparable data (Table) . Thus the increases in the level of IL-11 mRNA shown are specific and do not reflect variations of amplification. Furthermore, the yield of total RNA from colitis tissues was not significantly different from the untreated control rats (data not shown) and the quality of each total RNA sample was also comparable (Fig 7A) . These findings taken together support the conclusion that the changes in the level of IL-I13 mRNA reported in this study are real and specific.
In conclusion, we showed that the expression of IL- 1 13 
